Pergolide Remains Treatment of Choice for PPID
Pituitary pars intermedia dysfunction (PPID), often called equine Cushing’s disease, has been treated with the drug pergolide for years. The main reason pergolide was initially the treatment of choice was largely based on the drug’s effectiveness in treating people with Parkinson’s disease, a human endocrine disorder, according to Ronette Gehring, BVSc, MMedVet (Pharm), MRCVS, Dipl. ACVCP,




